OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.62+0.00 (0.00%)
Close on Nov 17, 2026Market cap $1.21BP/E –Yield –
OPKO Health pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
OPKO Health's pe ratio was 28.5× on Jan 31, 2022, against 52.3× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jan 31, 2022 | 28.5× | −15.3 |
| 2021 | Dec 31, 2021 | 43.7× | −8.6 |
| 2016 | Oct 31, 2016 | 52.3× | – |
See a number that looks wrong?